Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy

IJU-31-526

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

IJU-31-526.pdf

https://hama-med.repo.nii.ac.jp/record/2000470/files/IJU-31-526.pdf

application/pdf

ファイル	ライセンス
IJU-31-526.pdf (1.1 MB) sha256 2aa50d659da8de79e2d11bc5b46d7c7d4ee4d9ef541f0ed2996c1db2ead5637b

2025-07-25

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/非表示

Downloads

Plays